Arrowhead 制药 ARWR
$58.16 +$0.70 (+1.22%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $58.16 0.00%
开盘$58.21
昨收$57.46
当日区间$57.00 – $58.71
成交量1.36M
市值$8.22B
市盈率（TTM）–
股息率–
ARWR 相关新闻
匹配 Arrowhead Pharmaceuticals 或代码 ARWR 的头条新闻，按最新排序。
- Citi Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $108
- Citi Initiates Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Announces Target Price $108
- Goldman Sachs Maintains Arrowhead Pharmaceuticals(ARWR.US) With Hold Rating, Cuts Target Price to $74 负面
- H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $120
- J.P. Morgan Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating
- Citi Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating
- Morgan Stanley Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $120
- J.P. Morgan Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $100 正面
- H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $120 正面
- A Quick Look at Today's Ratings for Arrowhead Pharmaceuticals(ARWR.US), With a Forecast Between $89.59 to $126
- B. Riley Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $123
- RBC Capital Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $100
- Analysts Are Bullish on Top Healthcare Stocks: CapsoVision, Inc. (CV), Arrowhead Pharmaceuticals (ARWR) 正面
- TD Cowen Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating
- Stifel Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $104
暂无评论——快来第一个聊聊 ARWR。
登录后参与讨论。